Isobutyl iodide → 1-isobutyl-3-methylpyrimidine-2,4(1H,3H)-dione

HRID 2205652노트

반응식

HRID 2205652 반응식
[CH3:1][N:2]1[C:7](=[O:8])[CH:6]=[CH:5][NH:4][C:3]1=[O:9].[CH2:10](I)[CH:11]([CH3:13])[CH3:12].C(=O)([O-])[O-].[Cs+].[Cs+]>CN(C=O)C>[CH2:10]([N:4]1[CH:5]=[CH:6][C:7](=[O:8])[N:2]([CH3:1])[C:3]1=[O:9])[CH:11]([CH3:13])[CH3:12]

참가 물질

5

반응물 3

HCID 10556Isobutyl iodideHCID 10796Cesium carbonateHCID 790663-Methyluracil

생성물 1

HCID 674157251-isobutyl-3-methylpyrimidine-2,4(1H,3H)-dione

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

A suspension of 3-Methyluracil (3.0 g, 23.8 mmol), isobutyl iodide (7 mL, 60 mmol) and cesium carbonate (11.6 g, 35.7 mmol) in DMF (30 mL) is stirred at room temperature over a weekend. Solvent is removed under vacuum. The residue is treated with water, and then extracted with dichloromethane four times. The combined organic phase is washed with brine, dried over anhydrous sodium sulfate, and then filtered through a short silica gel column. The filtrate is concentrated to dryness to give product as off white solids, which is used in the next step without further purification. MS (ESI) m/z 183.1 [M+H]+.

후처리

  1. customSolvent is removed under vacuum
  2. additionThe residue is treated with water
  3. extractionextracted with dichloromethane four times
  4. washThe combined organic phase is washed with brine
  5. dry with materialdried over anhydrous sodium sulfate
  6. filtrationfiltered through a short silica gel column
  7. concentrationThe filtrate is concentrated to dryness
  8. customto give product as off white solids, which
  9. customis used in the next step without further purification

출처 및 근거

ORD 기록
ord-71f568db3e8f4e7bbbacaaf61828bbe4
출처 데이터셋
uspto-grants-2016_06
특허 번호
US09371327B2

반응 노트

불러오는 중…